These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
    Author: Liang J, Li Y, Wang N.
    Journal: Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242.
    Abstract:
    OBJECTIVE: To investigate the association of three single nucleotide polymorphisms (SNPs), i.e. -160C/A, -347G/GA and 3'UTR+ 54C/T, in the promoter region of E-cadherin gene (CDH1) with the risk of epithelial ovarian carcinoma. METHODS: The SNPs of CDH1 gene were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 207 epithelial ovarian carcinoma patients and 256 unrelated healthy women; immunohistochemistry was used to measure the level of CDH1 in different genotypes of 3'UTR+ 54C/T locus. RESULTS: There were no significant difference in the frequencies between patients and control women in the two loci (-160C/A, -347G/GA) of CDH1 gene (P> 0.05). However, there was significant difference in the frequency of CDH1 3'-UTR+ 54C/T genotypes (CC, CT and TT) between patients and controls (P< 0.05). The frequencies of the CC genotype and the C allele in patients (65.2%, 89.1%) were significantly higher than that in controls (52.7%ì64.5%) (P< 0.01). The CC genotype significantly increased the risk to epithelial ovarian carcinoma, with adjusted odds ratio of 1.85 (95%CI= 1.27-2.69). In the ovarian tissues of patients, the expression of CDH1 from CC genotype was significantly lower than that with the other genotypes (CT+ TT) (P< 0.05). The -160C/A and -347G/GA polymorphisms were in linkage disequilibrium (D'= 0.999582) by analyzing with 2LD software. The -160A/-347GA haplotype was only observed in patients (5.1%), the -160C/-347GA haplotype decreased susceptibility to epithelial ovarian carcinoma, with adjusted odds ratio of 0.66 (95%CI= 0.45-0.96). CONCLUSION: CDH1 -160C/A and -347G/GA polymorphisms were not associated with the risk of epithelial ovarian carcinoma. However, the haplotype may have impact on the risk of epithelial ovarian carcinoma. The CC genotype of 3'-UTR + 54CT may be a potential risk factor for the epithelial ovarian carcinoma.
    [Abstract] [Full Text] [Related] [New Search]